Identifying Plasma Biomarkers That Predict Patient-Reported Outcomes Following Treatment for Trapeziometacarpal Osteoarthritis Using Machine Learning
Open Access
- 10 October 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (20) , 9856
Abstract
Osteoarthritis (OA) in the trapeziometacarpal joint (TM) is a prevalent form of hand OA, yet research on biomarkers specific to hand OA remains limited. This study aims to identify systemic plasma biomarkers at baseline in TM OA patients that are associated with patient-reported outcomes one year post-treatment. Blood samples and clinical data were collected prospectively from 143 TM OA patients undergoing conservative therapy, fat grafting, or surgery, with one-year follow-up. Supervised machine learning with Lasso regularization analyzed associations among 10 systemic biomarkers related to cartilage turnover, bone remodeling, pain, or lipid metabolism. Generalized estimating equation models evaluated baseline biomarker associations with one-year outcomes. Patients averaged 61 years, were mostly female (69%), and were primarily treated conservatively (47%). The machine learning model identified associations between outcomes and biomarkers, including PIIANP, Visfatin, adiponectin, and leptin. Adjusted analyses revealed baseline PIIANP associated with VAS, QuickDASH, and TASD improvements, while Visfatin correlated with VAS worsening. We could identify two different plasma markers that could predict the clinical outcome of TM OA treatment. Baseline PIIANP is associated with improvement, while Visfatin is associated with worsening in TM OA outcomes up to one year post-treatment. Further prospective studies are needed to confirm and solidify these findings.Keywords
Funding Information
- Plastic Surgery Foundation (PSF National Endowment Grant)
- American Society for Surgery of the Hand (1407)
This publication has 26 references indexed in Scilit:
- Is increased trapezial slope a cause of early trapeziometacarpal osteoarthritis?Hand Surgery and Rehabilitation, 2023
- Biomarkers for osteoarthritis: Current status and future prospectsBest Practice & Research Clinical Rheumatology, 2023
- The current progress in understanding the molecular functions and mechanisms of visfatin in osteoarthritisJournal of Bone and Mineral Metabolism, 2016
- The 2014 ABJS Nicolas Andry Award: The Puzzle of the Thumb: Mobility, Stability, and Demands in OppositionClinical Orthopaedics and Related Research, 2014
- Biomarkers for osteoarthritis: Current position and steps towards further validationBest Practice & Research Clinical Rheumatology, 2014
- Prevalence of Doctor‐Diagnosed Thumb Carpometacarpal Joint Osteoarthritis: An Analysis of Swedish Health CareArthritis Care & Research, 2013
- In vivo reduction or blockade of interleukin-1β in primary osteoarthritis influences expression of mediators implicated in pathogenesisOsteoarthritis and Cartilage, 2012
- Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrixOsteoarthritis and Cartilage, 2009
- Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilageOsteoarthritis and Cartilage, 2008
- Classification of osteoarthritis biomarkers: a proposed approachOsteoarthritis and Cartilage, 2006